ONL Therapeutics

3 followers

‌

ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to protecting and improving the vision of patients with a range of retinal diseases and conditions.

Industries

Biotechnology

Headquarters

Ann Arbor, United States

Employees

1-10

Links

Org chart

David Esposito

President & CEO

David Esposito

Collapse

David Zacks

Co-Founder & Chief Science Officer

Connie Chang

Chief Operating Officer

Jana Van De Goor

Vice President Development

Amanda Maciel

Director Of Finance

Sushanta Mallick, PhD, MBA

Chief Development Officer

Wen Jing Chen

Chief Operating Officer

Xiao Ting Sun

Chief Operating Officer

Teams

Advisory

5 members

Operations Team

5 members

Leadership Team

4 members

Research and Development

4 members

Similar companies

Acclinate

1 follower

Thermo Fisher Scientific

173 followers

Genentech

158 followers

Gilead Sciences

133 followers

Biogen

118 followers

Regeneron

101 followers

Illumina

71 followers

Vertex Pharmaceuticals

62 followers

Verily Life Sciences

38 followers

BioMarin Pharmaceutical

36 followers

GRAIL

27 followers

Explore companies

��������